Log In
BCIQ
Print this Print this
 

ADU-214

  Manage Alerts
Collapse Summary General Information
Company Aduro Biotech Inc.
DescriptionBivalent Listeria-based immunotherapy that targets both mesothelin and an EGFR mutation
Molecular Target Mesothelin
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today